Publications by authors named "F Quenet"

Claim this Profile
O
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.
Alexandra Fauvre, Chiara Ursino, Veronique Garambois, Elodie Culerier, Louis-Antoine Milazzo, François Quenet

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.
Jean-Marc Classe, Pierre Meeus, Delphine Hudry, Romuald Wernert, François Quenet

Lancet Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor?
M Aubert, D Mege, D Goere, W Ezzedine, M Pocard, F Quenet

Eur J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study.
Alexis Trecourt, Naoual Bakrin, Olivier Glehen, Witold Gertych, Laurent Villeneuve, François Quenet

Ann Surg Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperthermic intraperitoneal chemotherapy in colorectal cancer.
Oliver M Fisher, Chris Brown, Jesus Esquivel, Stein G Larsen, Winston Liauw, Francois Quenet

BJS Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis